eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2005, Volume 1, Issue 3 : 230-236 doi: ijmmas.2005.230.236
Research Article
Essential Trans-synaptic Nonviability of Individual Neurons Characterized by Dysfunctional Neurofilament Aggregation in Amyotrophic Lateral Sclerosis
Published
Sept. 30, 2005
Abstract

Amyotrophic lateral sclerosis would constitute a system complex of heightened neuronal susceptibility that is dependent on skeletal myofiber participation towards further progression of such neuronal injury. Indeed, a simple concept of neurofilament disorganization and abnormal protein trafficking might implicate systems of direct and indirect consequence in inducing both myofiber denervation atrophy on a selective axonal basis of involvement and also a possible pathway of susceptibility towards further intraneuronal disorganization. Indeed, in terms of neuropathologic lesions such as neurofilament skeins and axonal spheroids in a complex setting of aggregation and inclusion bodies in the perikaryon, one might perhaps strictly recognize skeletal myofiber atrophy as a central target of pathology of motoneuron injury in a context however of further induced injury to such motoneurons as resulting from active myofiber atrophy. In simple terms, individual skeletal myofibers that atrophy on an individual axonal basis of injury would constitute a main mechanism for further self-propagation of progressive injury to the supplying axon. Indeed, amyotrophic lateral sclerosis would appear a disease process with active overcompensatory neuronal attempts at recovery further contributing to the disease activity.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Clinical Efficacy of Drug-Eluting Stents Among Hypertensive Patients
41-45
Occupational Health Risks Among Healthcare Workers: Prevalence, Determinants, Clinical Consequences, and Prevention Strategies
1-4
Healthcare Disparities and Equity in Medical Services: Challenges, Determinants, and Strategies for Achieving Equitable Healthcare
27-34
Professionalism and Ethics Education in Medical Schools: Assessing Knowledge, Attitudes, and Educational Outcomes Among Medical Students
16-20
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.